PROCEPT BioRobotics Cash Flow Statement (2020-2026) | PRCT

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-14.63M-17.94M-18.27M-19.64M-19.32M-39.54M-23.97M-77.96M-44.05M-30.04M-30.68M-41.54M-31.64M-35.05M-20.67M-24.74M-60.82M-60.75M-32.65M-31.64M
Share-based Compensation (Quarter)
0.72M0.93M-2.30M1.55M2.68M18.44M0.19M3.72M5.10M5.33M4.98M6.26M7.99M8.51M9.09M10.11M12.16M14.49M10.84M13.07M
Gains from Investment Securities (Quarter)
-0.02M-0.04M
Asset Writedowns and Impairment (Quarter)
0.11M0.09M-0.03M0.23M0.19M0.58M-0.99M0.91M0.38M0.60M0.33M0.16M0.08M-0.35M0.20M
Cash from Operations (Quarter)
-12.91M-12.75M-16.48M-18.23M-17.13M-19.85M-25.17M-35.93M-28.34M-18.94M-24.79M-32.29M-15.74M-18.80M-32.39M-16.98M-15.04M-6.63M-10.33M-38.13M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.85M0.80M0.76M0.76M0.72M0.70M0.66M0.79M0.64M1.05M1.32M1.18M1.27M1.33M1.45M1.48M1.59M1.62M1.71M1.74M
Change in Working Capital
Change in Receivables (Quarter)
1.01M1.21M-1.89M2.53M3.90M1.95M2.43M5.37M12.53M1.45M13.75M7.71M2.83M10.59M14.83M-3.93M2.71M4.35M-2.23M13.32M
Change in Inventory (Quarter)
1.83M0.82M2.54M-0.52M1.20M8.82M5.75M10.14M3.29M-0.48M-3.19M1.49M2.79M7.16M5.80M6.28M4.79M-0.57M4.00M7.03M
Change in Account Payables (Quarter)
1.42M0.24M-1.55M0.45M0.50M3.30M-0.28M2.23M0.01M-2.32M5.88M-2.31M0.34M5.19M-5.38M3.75M-2.25M-0.79M5.93M1.54M
Change in Accured Expenses (Quarter)
2.50M-1.46M1.60M-1.89M2.32M0.89M5.65M0.35M-3.84M3.82M3.12M0.03M1.40M0.52M-1.81M-6.56M8.12M-1.35M-0.07M-4.69M
Other Working Capital Changes (Quarter)
0.99M-1.41M-0.18M0.48M-0.10M1.68M0.08M0.28M0.50M0.68M-0.51M1.04M2.00M0.40M-1.48M1.76M2.22M-1.17M
Investing Activities
Capital Expenditures (Quarter)
0.19M-0.03M0.39M0.35M-0.08M1.51M1.76M5.34M5.37M5.78M-14.63M0.56M2.43M-2.96M0.32M1.39M3.25M2.87M1.85M2.91M
Cash from Investing Activities (Quarter)
-0.11M-0.11M-0.33M-0.06M-0.22M-1.51M-0.87M-5.34M-5.37M-5.78M-8.71M-1.95M-1.04M-0.25M-1.17M-1.84M-2.80M-2.87M-1.85M-2.91M
Financing Activities
Other financing activities (Quarter)
1.42M0.85M168.87M1.29M1.57M0.78M0.37M0.38M0.71M0.41M0.97M2.59M3.17M1.72M3.60M1.30M0.87M1.08M1.58M0.22M
Cash from Financing Activities (Quarter)
86.12M174.12M0.64M1.29M2.86M0.78M-1.32M0.38M2.43M162.12M2.87M2.59M5.30M1.72M170.53M1.30M4.38M1.08M4.44M0.22M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
85.00M-1.29M164.52M
Additional items
Exchange Rate Effect (Quarter)
-0.02M-0.01M-0.04M-0.04M
Change in Cash (Quarter)
73.11M161.26M-16.16M-17.00M-14.48M-20.59M-27.36M-40.89M-31.28M137.40M-30.64M-31.65M-11.48M-17.33M136.96M-17.52M-13.49M-8.44M-7.78M-40.86M
Free Cash Flow (Quarter)
-13.10M-12.72M-16.87M-18.58M-17.05M-21.36M-26.93M-41.27M-33.71M-24.72M-10.16M-32.84M-18.17M-15.84M-32.71M-18.37M-18.29M-9.50M-12.18M-41.04M
Net Cash Flow (Quarter)
73.11M161.26M-16.16M-17.00M-14.48M-20.59M-27.36M-40.89M-31.28M137.40M-30.64M-31.65M-11.48M-17.33M136.96M-17.52M-13.47M-8.43M-7.74M-40.82M